Cary Street Partners Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-30
| Closed | -$8.34K | – | 214 |
|
|
2023
Q1 | $8.34K | Hold |
30
| – | – | ﹤0.01% | 346 |
|
|
2022
Q4 | $8.31K | Buy |
30
+15
| +100% | +$4.15K | ﹤0.01% | 377 |
|
|
2022
Q3 | $4K | Buy |
+15
| New | +$4K | ﹤0.01% | 374 |
|
|
2022
Q2 | – | Sell |
-4,981
| Closed | -$1.05M | – | 157 |
|
|
2022
Q1 | $1.05M | Sell |
4,981
-545
| -10% | -$115K | 0.21% | 102 |
|
|
2021
Q4 | $1.33M | Sell |
5,526
-1,430
| -21% | -$343K | 0.28% | 86 |
|
|
2021
Q3 | $1.97M | Sell |
6,956
-93
| -1% | -$26.3K | 0.69% | 53 |
|
|
2021
Q2 | $2.44M | Sell |
7,049
-22,275
| -76% | -$7.71M | 0.58% | 54 |
|
|
2021
Q1 | $1.96M | Buy |
29,324
+2,518
| +9% | +$169K | 0.48% | 64 |
|
|
2020
Q4 | $1.79M | Buy |
+26,806
| New | +$1.79M | 0.53% | 60 |
|